Method for producing dihydroxyacetone-3-phosphate

Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Preparing organic compound containing a metal or atom other...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C435S148000, C435S150000, C435S194000, C435S252300, C435S252330, C435S254110, C435S320100, C536S023200

Reexamination Certificate

active

06451566

ABSTRACT:

TECHNICAL FIELD
The present invention relates to a method for producing dihydroxyacetone-3-phosphate using enzyme.
BACKGROUND ART
Dihydroxyacetone-3-phosphate is a substrate for fructose 1,6-bisphosphate aldolase and is used for stereoselectively synthesizing many kinds of carbohydrates by aldol condensation with various aldehydes. The carbohydrates thus synthesized can be widely utilized as medicines and their synthetic intermediates. The above reaction, however, requires large excesses of expensive dihydroxyacetone-3-phosphate, making the products expensive.
For example, dihydroxyacetone-3-phosphate can be chemically produced by directly phosphorylating dihydroxyacetone dimer with phosphorus oxychloride (POCl
3
) in pyridine (Tetrahedron Lett., 28, 1641 (1987)). This production method is complicated and thus cannot produce dihydroxyacetone-3-phosphate in a high yield at low cost.
Methods of producing dihydroxyacetone-3-phosphate using enzymes have also been reported. An example thereof is a method of synthesizing dihydroxyacetone-3-phosphate from dihydroxyacetone with immobilized glycerol kinase (GK) under conditions that ATP is regenerated by using phosphoenolpyruvic acid and pyruvate kinase (PK) (J. Org. Chem., 48, 3199(1983), and J. Am. Chem. Soc., 107, 7019(1985)). In this method, acetate kinase and acetylphosphate may be used instead of phosphoenolpyruvic acid and pyruvate kinase (J. Am. Chem. Soc., 107, 7019(1985)). These methods using glycerol kinase (GK) require highly purified enzymes and therefore cannot produce dihydroxyacetone-3-phosphate in a high yield at low cost.
For another example, it is theoretically possible to produce dihydroxyacetone-3-phosphate from dihydroxyacetone using dihydroxyacetone kinase (DHAK) (examined published Japanese patent applications (JP-B) No. Hei 4-29349 and Hei 4-22560). In particular, dihydroxyacetone kinase derived from yeast
Schizosaccharomyces pombe
is suitable for producing dihydroxyacetone-3-phosphate (JP-B Hei 4-29349). However, the cell extract of
Schizosaccharomyces pombe
contains coexisting enzymes such as phosphatases and triose-3-phosphate isomerase, which degrade the formed dihydroxyacetone-3-phosphate. The enzyme thus needs to be highly purified and has not yet been applied practically.
For the practical production of dihydroxyacetone-3-phosphate using enzymes, the enzyme or the biocatalyst containing the enzyme should have high reactivity, be prepared easily at low cost, and be highly purified so as not to degrade the product, dihydroxyacetone-3-phosphate. No efficient method for producing dihydroxyacetone-3-phosphate by using enzymes or biocatalysts containing the enzymes, which meets the above requirements, has been developed.
DISCLOSURE OF THE INVENTION
An objective of this invention is to provide a method, for efficiently producing dihydroxyacetone-3-phosphate.
Under the above circumstances, the present inventors have attempted to clone a gene encoding dihydroxyacetone kinase and to express it efficiently to obtain the practical enzyme. The present inventors have succeeded in overexpressing the enzyme in a microbial host. Furthermore, the present inventors have found that dihydroxyacetone-3-phosphate can be produced in a high concentration by contacting the host cells as they are or the enzyme produced by them with dihydroxyacetone, the substrate of the enzyme, thereby accomplishing the present invention.
More specifically, this present invention relates to:
(1) a method for producing dihydroxyacetone-3-phosphate, which comprises contacting dihydroxyacetone with bacterial cells transformed with the gene encoding dihydroxyacetone kinase or the enzyme produced by the bacterial cells;
(2) a method described in (1), wherein said dihydroxyacetone kinase is derived from yeast belonging to the genus Schizosaccharomyces;
(3) a method described in (1), wherein said dihydroxyacetone kinase is derived from
Schizosaccharomyces pombe;
(4) a method described in (1), wherein said bacterial cell is
Escherichia coli
; and
(5) a method described in any one of (1) to (4), wherein said contacting is performed under the conditions that coenzyme, ATP, is regenerated.
The source of the gene encoding dihydroxyacetone kinase used in the present invention is not limited. It is preferably derived from yeast belonging to the genus Schizosaccharomyces; more preferably,
Schizosaccharomyces pombe
; and still more preferably,
Schizosaccharomyces pombe
IFO 0354.The nucleotide sequence of the dihydroxyacetone kinase gene from
Schizosaccharomyces pombe
IFO 0354 is shown in SEQ ID NO: 1, and the deduced amino acid sequence is shown in SEQ ID NO: 2.
In the method of this invention, microorganisms transformed with dihydroxyacetone kinase capable of overexpressing the enzyme can be used as they are as an enzyme catalyst. The term “overexpression” as used herein means a higher level expression than spontaneous |expression. In general, transformants capable of overexpresing the expression product can be obtained by introducing multiple copies of the expression unit with the gene encoding the expression product into host cells. The host bacterial cells used in the present invention are not particularly limited. It is preferable to use bacteria belonging to the genus Escherichia, and more preferable to use
E. coli
K-12 strain because various host-vector systems can be used. For example, pUC118 or pUC119 is the preferable expression vector into which the dihydroxyacetone kinase gene is to be inserted (Methods in Enzymology, 153, 3 (1987)). The gene can be introduced into the host cell by methods well known in the art such as a method described in “Methods in Enzymology, 68, 299 (1979).” For example,
E. coli
capable of overexpressing dihydroxyacetone kinase can be prepared as described below. First, the primers are designed for polymerase chain reaction (PCR) based on the database resulting from genome analysis of
Schizosaccharomyces pombe
. The target DNA is amplified by PCR using the primers and genomic DNA isolated from
Schizosaccharomyces pombe
IFO 0354 as a template DNA by conventional procedures. The PCR products are ligated into appropriate vectors and are cloned. The gene-inserted vectors are transformed into an appropriate strain of
E. coli
, and the transformants are then selected by detecting the existence of drug resistant gene(s) and the DNA insert(s). The DHAK productivity of the clones is measured by assaying the activity of the enzyme.
The enzyme produced by the bacterial cells can be isolated from the cells for use in the method of the present invention. The enzyme is not necessarily purified. A crude enzyme is used as well as the purified enzyme. The dihydroxyacetone kinase can be recovered from the grown cells by extracting the enzyme from the cells first because the enzyme is produced intracellularly. Namely, the cells are collected from the culture medium by filtration or centrifugation and disrupted by mechanical methods such as treatment with alumina, dynomill, or ultrasonication to extract the enzyme in a soluble form. Alternatively, the cell membranes are destroyed by treatment with organic solvents such as acetone, and the resulting cells are dried under reduced pressure. The powder thus prepared is used as a catalyst containing the enzyme. Insoluble materials are removed from the culture obtained in the methods described above by filtration or centrifugation to obtain the crude enzyme. Furthermore, the crude enzyme is concentrated and purified by methods known in the art such as adsorption chromatography, ion exchange chromatography, and gel filtration chromatography. The thus-obtained, partially purified preparation of dihydroxyacetone kinase is also used in the method of this invention.
The dihydroxyacetone kinase activity of the
E. coli
strain that overexpresses the enzyme or the enzyme isolated from said cells is measured by known methods (JP-B Hei 04-29349) as follows. The decrease of absorbance at 340 nm is spectrophotometrically measured during the reaction at 25° C. in 1 ml of the reaction mixture con

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Method for producing dihydroxyacetone-3-phosphate does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for producing dihydroxyacetone-3-phosphate, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for producing dihydroxyacetone-3-phosphate will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2837738

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.